Greig NH - Search Results

1

Differential effects of two hexahydropyrroloindole carbamate-based anticholinesterase drugs on the amyloid beta protein pathway involved in Alzheimer's disease.

Lahiri DK, Alley GM, Tweedie D, Chen D, Greig NH. Lahiri DK, et al. Among authors: greig nh. Neuromolecular Med. 2007;9(2):157-68. doi: 10.1007/BF02685889. Neuromolecular Med. 2007. PMID: 17627035

2

Effects of cholinesterase inhibitors on the secretion of beta-amyloid precursor protein in cell cultures.

Lahiri DK, Farlow MR, Nurnberger JI Jr, Greig NH. Lahiri DK, et al. Among authors: greig nh. Ann N Y Acad Sci. 1997 Sep 26;826:416-21. doi: 10.1111/j.1749-6632.1997.tb48495.x. Ann N Y Acad Sci. 1997. PMID: 9329715

3

The experimental Alzheimer drug phenserine: preclinical pharmacokinetics and pharmacodynamics.

Greig NH, De Micheli E, Holloway HW, Yu QS, Utsuki T, Perry TA, Brossi A, Ingram DK, Deutsch J, Lahiri DK, Soncrant TT. Greig NH, et al. Acta Neurol Scand Suppl. 2000;176:74-84. doi: 10.1034/j.1600-0404.2000.00311.x. Acta Neurol Scand Suppl. 2000. PMID: 11261809

4

Cholinesterase inhibitors, beta-amyloid precursor protein and amyloid beta-peptides in Alzheimer's disease.

Lahiri DK, Farlow MR, Hintz N, Utsuki T, Greig NH. Lahiri DK, et al. Among authors: greig nh. Acta Neurol Scand Suppl. 2000;176:60-7. doi: 10.1034/j.1600-0404.2000.00309.x. Acta Neurol Scand Suppl. 2000. PMID: 11273593

5

Phenserine regulates translation of beta -amyloid precursor protein mRNA by a putative interleukin-1 responsive element, a target for drug development.

Shaw KT, Utsuki T, Rogers J, Yu QS, Sambamurti K, Brossi A, Ge YW, Lahiri DK, Greig NH. Shaw KT, et al. Among authors: greig nh. Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7605-10. doi: 10.1073/pnas.131152998. Epub 2001 Jun 12. Proc Natl Acad Sci U S A. 2001. PMID: 11404470 Free PMC article.

6

A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells.

Perry T, Lahiri DK, Chen D, Zhou J, Shaw KT, Egan JM, Greig NH. Perry T, et al. Among authors: greig nh. J Pharmacol Exp Ther. 2002 Mar;300(3):958-66. doi: 10.1124/jpet.300.3.958. J Pharmacol Exp Ther. 2002. PMID: 11861804

7

A new therapeutic target in Alzheimer's disease treatment: attention to butyrylcholinesterase.

Greig NH, Utsuki T, Yu Q, Zhu X, Holloway HW, Perry T, Lee B, Ingram DK, Lahiri DK. Greig NH, et al. Curr Med Res Opin. 2001;17(3):159-65. doi: 10.1185/0300799039117057. Curr Med Res Opin. 2001. PMID: 11900310 Review.

8

Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer's disease.

Sambamurti K, Greig NH, Lahiri DK. Sambamurti K, et al. Among authors: greig nh. Neuromolecular Med. 2002;1(1):1-31. doi: 10.1385/NMM:1:1:1. Neuromolecular Med. 2002. PMID: 12025813 Review.

9

Nicotine reduces the secretion of Alzheimer's beta-amyloid precursor protein containing beta-amyloid peptide in the rat without altering synaptic proteins.

Lahiri DK, Utsuki T, Chen D, Farlow MR, Shoaib M, Ingram DK, Greig NH. Lahiri DK, et al. Among authors: greig nh. Ann N Y Acad Sci. 2002 Jun;965:364-72. doi: 10.1111/j.1749-6632.2002.tb04178.x. Ann N Y Acad Sci. 2002. PMID: 12105112

10

An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript.

Rogers JT, Randall JD, Cahill CM, Eder PS, Huang X, Gunshin H, Leiter L, McPhee J, Sarang SS, Utsuki T, Greig NH, Lahiri DK, Tanzi RE, Bush AI, Giordano T, Gullans SR. Rogers JT, et al. Among authors: greig nh. J Biol Chem. 2002 Nov 22;277(47):45518-28. doi: 10.1074/jbc.M207435200. Epub 2002 Aug 26. J Biol Chem. 2002. PMID: 12198135 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

411 results

Search Page

Filters